Skip to main content

Dianthus Therapeutics, Inc.

DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001690585

In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Dianthus Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
72
−1 vs. Q2 2022
Shares held
46.6M
+1.10M (+2.4%) vs. Q2 2022
Total value
$65.8M
+$11.2M (+20.5%) vs. Q2 2022
New holders
8
17 more added
Sold out
9
24 more reduced

2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 72 institutions
Q1 2021: 90 institutionsQ2 2021: 97 institutionsQ3 2021: 93 institutionsQ4 2021: 94 institutionsQ1 2022: 93 institutionsQ2 2022: 75 institutionsQ3 2022: 72 institutionsQ4 2022: 54 institutionsQ1 2023: 52 institutionsQ2 2023: 46 institutionsQ3 2023: 30 institutionsQ4 2023: 39 institutionsQ1 2024: 76 institutionsQ2 2024: 74 institutionsQ3 2024: 91 institutionsQ4 2024: 96 institutionsQ1 2025: 99 institutionsQ2 2025: 103 institutionsQ3 2025: 140 institutionsQ4 2025: 166 institutionsQ1 2026: 241 institutionsQ2 2026: 269 institutions
Value heldQ3 2022: $65.8M
Q1 2021: $418.4MQ2 2021: $366.3MQ3 2021: $276.0MQ4 2021: $211.4MQ1 2022: $138.9MQ2 2022: $54.6MQ3 2022: $65.8MQ4 2022: $11.1MQ1 2023: $23.6MQ2 2023: $22.0MQ3 2023: $136.3MQ4 2023: $106.5MQ1 2024: $782.3MQ2 2024: $768.8MQ3 2024: $858.7MQ4 2024: $765.7MQ1 2025: $685.5MQ2 2025: $728.6MQ3 2025: $1.84BQ4 2025: $2.02BQ1 2026: $5.18BQ2 2026: $6.40B
Institutions holding DNTH and their total value by quarter
QuarterHoldersValue
Q2 2026269$6.40B
Q1 2026241$5.18B
Q4 2025166$2.02B
Q3 2025140$1.84B
Q2 2025103$728.6M
Q1 202599$685.5M
Q4 202496$765.7M
Q3 202491$858.7M
Q2 202474$768.8M
Q1 202476$782.3M
Q4 202339$106.5M
Q3 202330$136.3M
Q2 202346$22.0M
Q1 202352$23.6M
Q4 202254$11.1M
Q3 202272$65.8M
Q2 202275$54.6M
Q1 202293$138.9M
Q4 202194$211.4M
Q3 202193$276.0M
Q2 202197$366.3M
Q1 202190$418.4M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q2 2022.

Institutions holding DNTH in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
TRV GP IV, LLC6,758,204$9.53M5.57%00.0%Unchanged
Deep Track Capital, LP5,359,000$7.56M0.37%00.0%Unchanged
Ra Capital Management, L.P.3,588,081$5.06M0.11%+3,588,081New
Atlas Venture Life Science Advisors, LLC3,476,536$4.90M0.54%00.0%Unchanged
Janus Henderson Group PLC3,308,899$4.75M0.00%+305,124+10.2%Added
Alphabet Inc.3,339,138$4.71M0.24%00.0%Unchanged
OrbiMed Advisors LLC2,250,953$3.17M0.06%00.0%Unchanged
TCG Crossover Management, LLC2,124,122$3.00M0.90%00.0%Unchanged
Millennium Management LLC2,095,342$2.95M0.00%+219,947+11.7%Added
Vanguard Group Inc1,963,432$2.77M0.00%+55,650+2.9%Added
Woodline Partners LP1,304,946$1.84M0.03%+371,765+39.8%Added
Wellington Management Group LLP1,286,230$1.81M0.00%−9,131−0.7%Reduced
Great Point Partners LLC1,019,091$1.44M0.35%−150,909−12.9%Reduced
Adage Capital Partners GP, L.L.C.818,650$1.15M0.00%+112,700+16.0%Added
BlackRock Inc.737,887$1.04M0.00%−57,479−7.2%Reduced
Gilder Gagnon Howe & Co LLC705,217$994.0K0.02%−40,772−5.5%Reduced
Laurion Capital Management LP582,300$821.0K0.02%00.0%Unchanged
Bleichroeder LP484,400$683.0K0.14%00.0%Unchanged
Palo Alto Investors LP432,300$610.0K0.05%00.0%Unchanged
Renaissance Technologies LLC404,851$571.0K0.00%−326,495−44.6%Reduced
Integral Health Asset Management, LLC377,000$532.0K0.11%+48,731+14.8%Added
RBF Capital, LLC371,422$524.0K0.04%00.0%Unchanged
Geode Capital Management, LLC350,436$494.0K0.00%+6,566+1.9%Added
Harvard Management Co Inc332,610$469.0K0.06%00.0%Unchanged
Casdin Capital, LLC320,000$451.0K0.03%−2,095,000−86.7%Reduced
Two Sigma Advisers, LP287,400$405.0K0.00%−82,900−22.4%Reduced
Bessemer Group Inc237,277$335.0K0.00%00.0%Unchanged
Credit Suisse AG193,500$273.0K0.00%−160.0%Reduced
Hellman Jordan Management Co Inc181,964$257.0K0.45%−113,036−38.3%Reduced
Harbor Capital Advisors, Inc.164,353$232.0K0.22%+5,046+3.2%Added
BIT Capital GmbH171,729$230.1K0.04%+95,229+124.5%Added
Dimensional Fund Advisors LP152,984$216.0K0.00%−5,093−3.2%Reduced
Bridgeway Capital Management, LLC147,200$208.0K0.01%00.0%Unchanged
State Street Corp139,207$196.0K0.00%+12,500+9.9%Added
Two Sigma Investments, LP131,059$185.0K0.00%−70,509−35.0%Reduced
Cornercap Investment Counsel Inc130,756$184.0K0.03%+49,802+61.5%Added
Ergoteles LLC115,122$162.0K0.01%−16,155−12.3%Reduced
Goldman Sachs Group Inc111,761$158.0K0.00%−10,626−8.7%Reduced
Acadian Asset Management LLC95,042$132.0K0.00%+21,102+28.5%Added
Northern Trust Corp86,611$122.0K0.00%+435+0.5%Added
Connor, Clark & Lunn Investment Management Ltd.86,631$122.0K0.00%+53,411+160.8%Added
MYDA Advisors LLC60,000$85.0K0.05%00.0%Unchanged
Cheyne Capital Management (UK) LLP47,170$67.0K0.14%00.0%Unchanged
Citadel Advisors LLC40,259$56.0K0.00%+40,259New
Fiduciary Trust Co30,555$43.0K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc27,369$39.0K0.00%+27,369New
Qube Research & Technologies Ltd20,414$29.0K0.00%−2,066−9.2%Reduced
Cerity Partners LLC20,000$28.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp16,084$23.0K0.00%00.0%Unchanged
Morgan Stanley15,415$22.0K0.00%−14,392−48.3%Reduced
Virtu Financial LLC12,954$18.0K0.00%−64,115−83.2%Reduced
Tower Research Capital LLC (TRC)12,589$18.0K0.00%+477+3.9%Added
Balyasny Asset Management LLC12,173$17.0K0.00%+12,173New
LMR Partners LLP10,671$15.0K0.00%00.0%Unchanged
Rathbone Brothers plc10,000$14.0K0.00%00.0%Unchanged
UBS Group AG8,264$12.0K0.00%+8,264New
Barclays PLC7,247$10.0K0.00%−1,399−16.2%Reduced
Royal Bank of Canada5,385$8.00K0.00%+1,063+24.6%Added
BNP Paribas Arbitrage, SA5,191$7.32K0.00%−22,643−81.4%Reduced
JPMorgan Chase & Co3,189$4.00K0.00%−459,654−99.3%Reduced
Rockefeller Capital Management L.P.3,000$4.00K0.00%−600−16.7%Reduced
Wells Fargo & Company2,245$3.00K0.00%−3,359−59.9%Reduced
Simplex Trading, LLC1,648$2.00K0.00%−255−13.4%Reduced
FMR LLC570$1.00K0.00%−200−26.0%Reduced
Citigroup Inc701$1.00K0.00%−478−40.5%Reduced
Umb Bank N A742$1.00K0.00%00.0%Unchanged
Axiom Investment Management LLC500$1.00K0.00%+500New
China Universal Asset Management Co., Ltd.551$1.00K0.00%+551New
Bank of America Corp171$00.00%+136+388.6%Added
Daiwa Securities Group Inc.106$00.00%00.0%Unchanged
Institutional & Family Asset Management, LLC50$00.00%00.0%Unchanged
Allworth Financial LP325$00.00%+325New
Federated Hermes, Inc.0$00.00%−189,312−100.0%Sold out
First Trust Advisors LP0$00.00%−55,275−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−53,026−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−45,968−100.0%Sold out
Crestline Management, LP0$00.00%−26,134−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−10,667−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−10,752−100.0%Sold out
Legal & General Group Plc0$00.00%−2,389−100.0%Sold out
New York State Common Retirement Fund0$00.00%−244−100.0%Sold out
B. Riley Wealth Management, Inc.––––Not filed
Brewin Dolphin Wealth Management Ltd––––Not filed